Stock Markets May 14, 2026 09:08 AM

Cerebras Lists on Nasdaq in Biggest U.S. IPO of the Year, Testing Appetite for AI Stocks

Santa Clara chipmaker raises $5.55 billion at $185 a share as institutional demand overwhelms supply

By Marcus Reed

Cerebras Systems began trading on the Nasdaq Global Select Market after pricing 30 million shares at $185 each, raising $5.55 billion and implying a fully diluted valuation above $56 billion. The offering was heavily oversubscribed, and the debut will serve as an indicator of investor interest in forthcoming AI-related IPOs.

Cerebras Lists on Nasdaq in Biggest U.S. IPO of the Year, Testing Appetite for AI Stocks

Key Points

  • Cerebras priced its IPO at $185 per share and raised $5.55 billion by selling 30 million shares.
  • The company's Wafer-Scale Engine contains 4 trillion transistors and 900,000 cores and competes in the AI inference market; it has secured a $20 billion, 750-megawatt deal with OpenAI and a partnership with Amazon Web Services.
  • Financials show 2025 revenue of $510 million (up 75% year-over-year) and an operating loss of $345 million, while remaining performance obligations total $24.6 billion.

Summary: Cerebras Systems priced its initial public offering at $185 per share and started trading on the Nasdaq Global Select Market, raising $5.55 billion from the sale of 30 million shares. The final price and size far exceeded earlier guidance, and the offering drew extremely strong institutional demand. The listing will act as a gauge of investor appetite for new AI-related public offerings.


Deal details and market reaction

Cerebras Systems Inc priced its IPO at $185 a share on Wednesday and began trading on the Nasdaq Global Select Market the following day. The company sold 30 million shares in the offering, producing $5.55 billion in proceeds. Prior guidance had been 28 million shares at $115-$125 each; that range was raised to $150-$160 during the roadshow before the final $185 price was set.

The final pricing implies a fully diluted enterprise valuation in excess of $56 billion, more than twice Cerebras' roughly $23 billion private valuation reported in February 2026. Underwriters Morgan Stanley, Citigroup, Barclays, and UBS hold a 30-day option to purchase up to an additional 4.5 million shares, which could add as much as $832.5 million to total proceeds if exercised in full.

Demand for the shares outpaced supply by a wide margin. Institutional orders were reported to exceed available stock by more than 20 times, a dynamic that prompted two increases in both the price range and the share count during the company's investor roadshow.


Product and commercial traction

Cerebras manufactures the Wafer-Scale Engine, an architecture that uses an entire silicon wafer rather than slicing it into smaller individual chips. The company's device contains 4 trillion transistors and 900,000 cores, placing it in competition with existing providers in the AI inference market.

The company has secured significant commercial agreements in recent months. In early 2026 Cerebras signed a $20 billion deal with OpenAI that spans 750 megawatts. In March Amazon Web Services announced a partnership to offer the wafer-scale product to its cloud customers; as part of that relationship, Amazon reportedly purchased $270 million of Cerebras stock.


Financial picture

For the year ended December 31, 2025, Cerebras reported revenue of $510 million, up 75% from $290.3 million in the prior year, according to its SEC filing. The company recorded an operating loss of $345 million for the same period. Notably, Cerebras disclosed $24.6 billion in remaining performance obligations - contractually committed but not yet recognized revenue - an amount roughly 48 times its 2025 sales level.


History of the offering and strategic interest

This public offering marks Cerebras' second attempt to list. The company first filed in 2024 but withdrew after its partnership with U.A.E.-based AI firm G42, which had accounted for more than 80% of Cerebras' revenue in the first half of that year, triggered a national security review by the Committee on Foreign Investment in the United States. The committee subsequently cleared the arrangement.

Reports earlier in the week indicated that Arm Holdings and SoftBank Group Corp. had mounted a last-minute acquisition approach; those reports said Cerebras declined the offer.


Wider implications

The timing of Cerebras' debut comes amid a strong market for new issues tied to artificial intelligence and defense. U.S. IPO proceeds have risen to $22.3 billion year-to-date in 2026, with Cerebras alone accounting for roughly one-quarter of that total. Several large technology and AI-related listings, including planned offerings from SpaceX, OpenAI, and Anthropic, are anticipated later in the year. Market participants view Cerebras' public offering as an early test of how much investor demand remains for AI-focused equity issuances.


Bottom line

Cerebras' debut is notable for the scale of capital raised and the intensity of institutional demand. The combination of a wafer-scale product design, large contracted orders, and major cloud-provider partnerships underpins the company's commercial narrative, while the elevated valuation and the concentration of future contractual revenue create distinct financial dynamics that investors and market watchers will be parsing as additional AI-related IPOs approach the market.

Risks

  • High valuation relative to recent private-market pricing - implied fully diluted valuation exceeds $56 billion versus a roughly $23 billion private valuation in February 2026 - which could affect investor expectations for returns.
  • Concentration of future revenue in long-term contractual commitments - $24.6 billion in remaining performance obligations is about 48 times 2025 sales, creating execution and recognition risk.
  • Dependence on large strategic partners and the prior CFIUS review related to the G42 relationship indicate potential regulatory and customer-concentration uncertainties that could materially affect operations.

More from Stock Markets

Microbot Medical Shares Slide After Short Seller Flags Questions About LIBERTY Robot May 14, 2026 STAAR Surgical Shares Jump After Blowout Q1 2026 Results and China Momentum May 14, 2026 Barclays Singles Out Five U.S. Memory Names as Beneficiaries of $1 Trillion AI Infrastructure Buildout May 14, 2026 Airlines Alter Schedules as Middle East Conflict Disrupts Routes May 14, 2026 Concorde International Shares Jump After Securing Over $10M in Multi-Year Security Contracts May 14, 2026